Almirall enters partnership with Inserm Transfert to research vitiligo
![Photo: Mikkel Aabenhus Hemmingsen / MedWatch](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14034088.ece/ALTERNATES/schema-16_9/doc7l1mot0aqrm70zdkimh.jpg)
Spanish skin health firm Almirall has entered a licensing and research collaboration with Inserm Transfers, a private subsidiary of Inserm, which is the French National Institute of the Health and Medical Research, the company reports in a press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.